Clinical Trials Browser

OTHER × ALK-positive Non-small Cell Lung Cancer × Clear all

NCT06361589 2024-04-12

Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients

ALK-positive Non-small Cell Lung Cancer

NCT02513667 2023-02-03

Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma

Phase 2 Terminated

14 enrolled 12 charts

ALK-positive Non-small Cell Lung Cancer